| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $277,557,034 ) (Continued on the next page) |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | U19AG071754 | North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2) | 003 | 5 | NIH | 4/22/2026 | $9,785 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R35GM136415 | Molecular Biophysics of Mitochondrial Membranes | 001 | 8 | NIH | 5/4/2026 | $738,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30AI197460 | Characterizing a Novel Toxin in Interbacterial Competition Among B. fragilis | 002 | 1 | NIH | 4/22/2026 | $576 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R35GM126928 | Enhancing Innate and Adaptive Immunity to Improve Sepsis Survival | 000 | 9 | NIH | 5/1/2026 | $575,370 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | UG1CA233339 | WASHINGTON UNIVERSITY / SITEMAN CANCER CENTER LEAD ACADEMIC SITE | 000 | 7 | NIH | 4/29/2026 | $1,612,916 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | U24HL127777 | Coordination Center for Programs for Individuals Engaged in Health-Related Research (PRIDE) | 001 | 16 | NIH | 4/29/2026 | $16,009 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K25AG083057 | Identification and characterization of molecular subtypes of Alzheimer's disease associated with cognitive function through cross-omics data integration | 000 | 4 | NIH | 3/31/2026 | $148,581 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K12NS129164 | Neurosurgeon Research Career Development Program (NRCDP) | 000 | 4 | NIH | 5/7/2026 | $1,662,385 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AI183261 | Microbial and Host Factors in the Progression to Celiac Disease | 000 | 3 | NIH | 4/28/2026 | $764,474 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DK136810 | Dopaminergic control of obesity in mice | 000 | 4 | NIH | 4/28/2026 | $530,596 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R35HL161185 | Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure | 001 | 5 | NIH | 4/23/2026 | $27,990 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01GM163062 | Real-Time Software-Hardware Integration for Dynamic Control of Tissue Mechanical Environments | 000 | 1 | NIH | 3/31/2026 | $1,244,000 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R13HD122400 | Membrane Excitability and Reproductive Biology | 000 | 1 | NIH | 5/1/2026 | $20,000 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DK134437 | The role of beta-cell crinophagy in generating diabetogenic neoepitopes | 000 | 4 | NIH | 4/27/2026 | $574,493 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DE032371 | Dissecting hybrid epithelial-mesenchymal states in head and neck cancer | 001 | 4 | NIH | 4/15/2026 | $39,375 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K99CA297000 | SERPINE family genes in rhabdoid tumorigenesis | 001 | 2 | NIH | 4/16/2026 | $11,337 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA297167 | Mechanism of acid signaling in bone organ metastases on tumor and myeloid cell evolution towards immune suppression and tumor progression | 001 | 2 | NIH | 4/16/2026 | $64,533 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA307529 | Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare | 000 | 1 | NIH | 4/17/2026 | $425,088 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01NS097799 | Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease | 001 | 9 | NIH | 4/24/2026 | $587,876 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA285272 | Cross-species development and credentialing of pediatric AML models | 001 | 3 | NIH | 4/16/2026 | $64,761 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30CA298121 | Dissecting how activated immunity reshapes the stromal TME of pancreatic ductal adenocarcinoma | 001 | 2 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA258325 | Hepatic steatosis promotes liver metastasis | 002 | 5 | NIH | 4/16/2026 | $43,418 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | T32HD043010 | Training of the Pediatric Physician-Scientist | 000 | 24 | NIH | 4/17/2026 | $308,056 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA237149 | Metabolic Control of Innate and Adaptive Immunity in Breast Cancer | 001 | 6 | NIH | 4/16/2026 | $42,018 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA260112 | Impact of cancer predisposition on oncogenic process, microenvironment, and treatment | 001 | 5 | NIH | 4/16/2026 | $47,537 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA270030 | Role of Osterix+ Osteolineage Cells in Primary and Metastatic Breast Cancer | 001 | 4 | NIH | 4/16/2026 | $43,779 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R00CA256039 | Dissecting reciprocal interactions between cancer cells and endothelial cells in SCLC liver metastasis. | 001 | 5 | NIH | 4/16/2026 | $24,900 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | U24NS107230 | Mid-America Regional Coordinating Center (MARCC) | 000 | 8 | NIH | 3/19/2026 | $416,921 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R37CA279596 | HPV genomic structure in cervical cancer radiation response and recurrence detection | 000 | 4 | NIH | 4/17/2026 | $501,912 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA260066 | Molecular Biomarkers of Long-Term Response to Androgen Deprivation Therapy and Radiation in Prostate Cancer | 001 | 5 | NIH | 4/16/2026 | $62,490 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01NS129742 | Migraine Onset in Adolescent Girls | 001 | 4 | NIH | 3/19/2026 | $62,786 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R35GM152192 | Control of germline stem cells and the switch to meiotic development in C. elegans | 001 | 3 | NIH | 3/18/2026 | $38,875 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K01HL167993 | K01 Career Development Award | 000 | 3 | NIH | 3/19/2026 | $163,702 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R03CA308660 | Risk-Based Prostate Cancer Screening: Perceptions and Informational Needs of Screening-Eligible Men | 000 | 1 | NIH | 4/24/2026 | $160,093 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21HD115568 | Peripheral and central mechanisms of endometriosis pain | 000 | 2 | NIH | 4/24/2026 | $194,375 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA276174 | Sonobiopsy for Noninvasive Genetic Evaluation of Glioblastoma Patients | 001 | 4 | NIH | 4/16/2026 | $64,532 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01NS124767 | Effects of ventricular volume and cerebral connectivity on neurological outcomes in preterm intraventricular hemorrhage | 001 | 5 | NIH | 3/19/2026 | $59,653 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DE032865 | Deciphering epigenetically-regulated pathways to improve targeted therapy for invasion and metastasis in head and neck cancer | 001 | 4 | NIH | 4/16/2026 | $60,603 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01NS140256 | Precision mapping of Parkinson's Disease pathophysiology in the Somato-Cognitive Action Network’s DBS targets | 001 | 2 | NIH | 3/19/2026 | $61,569 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R37CA276498 | Reversing Drug Resistance in Tumors with Clickable Antibody Pairs | 001 | 4 | NIH | 4/16/2026 | $64,310 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | UG1CA286946 | Siteman Cancer Center Catchment CSRN ACCESS Hub | 001 | 3 | NIH | 4/16/2026 | $87,469 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DA046224 | Prenatal Cannabis Exposure (PreCE) and Immune-Endocannabinoid Pathways to Development of Offspring Brain and Behavior up to Age 6 | 000 | 7 | NIH | 4/17/2026 | $1,636,390 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R37CA285572 | Decoding 41BB-specific dysfunction programs in cellular immunotherapies for cancer | 001 | 3 | NIH | 4/16/2026 | $35,570 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R37CA259359 | Dysregulated genome architecture in acute myeloid leukemia | 001 | 5 | NIH | 4/16/2026 | $35,570 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01NS134885 | Circadian interventions against glioblastoma | 001 | 3 | NIH | 3/19/2026 | $44,773 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01HL177113 | Development and Application of Chemical Biology Approaches for Understanding Protein Arginylation | 001 | 2 | NIH | 3/19/2026 | $18,288 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31CA294971 | Development and Validation of an Implementation Penetration Assessment Criteria Tool (ImPACT-HPV) for HPV Vaccination in Nigeria | 001 | 2 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA258690 | Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer | 001 | 5 | NIH | 4/16/2026 | $48,281 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA266041 | Understanding the role of DNA damage repair in racial disparities of triple-negative breast cancer outcomes | 001 | 5 | NIH | 4/16/2026 | $44,349 |
|
